Disprz, a Chennai, India-based Skill-development platform, raised $13 million (around Rs 96 crores) in a Series B funding. The round was led by Dallas Venture Capital and Mars Growth Capital. Other investors who participated in this round include Go1 (an Australian unicorn), Tara India Fund IV being managed by KOIS, …

Lacework, a San Jose, Calif.-based data-driven security platform for the cloud raised $1.3 billion on an $8.3 billion valuation to double down on the channel. Series D round was led by existing investors Sutter Hill Ventures, Altimeter Capital, D1 Capital Partners, and Tiger Global Management. New investors include Counterpoint Global …

Comet, a New York-based provider of the development platform for enterprise machine learning (ML) teams, raised $50 million in Series B funding. The round was led by OpenView, with participation from existing investors Scale Venture Partners, Trilogy Equity Partners, and Two Sigma Ventures. In addition, Ofer Bengal, Founder and CEO …

Gradle Inc., a San Francisco, CA-based provider of solutions that accelerate software developer productivity, closed a $27 milliion in Series C funding. The round was led by Triangle Peak Partners, with participation from True Ventures, DCVC, Bain Capital Ventures, Harmony Partners, and StepStone Group. The company intends to invest further …

Laminar, a Tel Aviv and New York-based public cloud data protection provider, emerged from stealth with a $32 million Series A investment, bringing the company’s total funding to $37 million. The round was led by New York-based global venture capital and private equity firm Insight Partners, with participation from SentinelOne …

Kandji, a San Diego, California-based next-generation Apple device management and security solution, announced that it raised $100 million in Series C funding at a nearly 10x increase in valuation since the company’s Series A funding round one year ago. The round was led by Tiger Global, with participation from Definition, …

Generate Biomedicines, a Cambridge, Massachusetts-based whose machine learning-powered Generative Biology platform that can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics, today announced it has raised $370 Million in a Series B financing to advance the development of its novel drug generation …